Century Therapeutics Reports Third Quarter 2026 Results
Company reported third quarter financial results and updated on clinical-stage programs, including CNTY-813 for Type 1 Diabetes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed